IOMED developed, manufactured, and marketed controllable drug delivery systems using iontophoretic technology. IPO (AMEX: IOX).


Genicon developed a proprietary system for detecting very minute quantities of biological compounds more simply and less expensively. Acquired by Invitrogen.


deNovis developed a technology platform for health insurance administrators.


Carefx is a provider of healthcare interoperability solutions including identity and access management and enterprise portals for hospitals, Regional Health Information Organizations (RHIOs) and Health Information Exchanges (HIEs). Acquired by Harris Corp.


BloXR has developed and is commercializing novel, easy to use products for protection against the harmful effects of ionizing radiation.


Axonix developed and manufactured peripherals for portable computers.


AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element. Acquired by Spectranetics (NASDAQ: SPNC)


Anesta Corp. developed and patented a method of delivering controlled therapeutic doses of potent systemic drugs via the oral mucosal tissues. IPO/Acquired by Cephalon (NASDAQ: CEPH)

Prev pageNext page